Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated about 6 hours ago
Private Swiss biotechs hit record funding amid slowdown in public financing
about 6 hours ago
Funding for privately traded Swiss biotechs hit a new high last year...
Vertex drops Moderna-partnered inhaled cystic fibrosis candidate after unresolved tolerability issues
about 10 hours ago
After pausing a trial for a Moderna-partnered cystic fibrosis candidate due to...
Passage launches strategic review and 75% layoffs after gene therapy path blocked by FDA
about 15 hours ago
After some tough feedback from the FDA on the path forward for...
‘A concerted industry-government effort’: Strand Therapeutics CEO Jake Becraft on FDA’s IND reform and China
about 16 hours ago
For Jake Becraft, Ph.D., the future of America’s biomedical innovation isn’t just...
Nuvalent teams up with Guardant Health for companion diagnostics
about 16 hours ago
Massachusetts biotech Nuvalent is turning to Guardant Health to develop companion diagnostics...
Mirum maps FDA path after anti-itch candidate scores ph. 2 win
about 17 hours ago
Mirum Pharmaceuticals is moving toward an FDA filing after its small molecule...
Takeda pivotal trial win improves convenience for PID patients relative to HyQvia
about 17 hours ago
A pivotal study of a Takeda primary immunodeficiency disease (PID) asset has...
Windward catches $165M breeze to fuel long-acting TSLP ambitions
about 18 hours ago
Windward Bio is in full sail with a $165 million crossover financing...
Celcuity’s gedatolisib beats Novartis’ Piqray in phase 3 breast cancer study
about 20 hours ago
A phase 3 trial of Celcuity’s pan-PI3K/mTOR inhibitor has hit its primary...
UCB inks $2B Candid buyout to join Gilead in autoimmune field
about 21 hours ago
UCB has struck a deal to acquire Candid Therapeutics for $2 billion...
‘Real momentum’ or ‘completely absurd’? How Trump’s support has shaken up psychedelics
1 day ago
The Trump administration's support could launch psychedelics across the regulatory finish line...
Genomics inks partnership deal with Greywolf to assess gene datasets
4 days ago
Genomics inked a partnership deal with fellow U.K.-based biotech Greywolf Therapeutics to...